Somasekar Seshagiri

Somasekar Seshagiri has a diverse and extensive work experience in the biotechnology industry. Somasekar currently holds the position of CEO/CSO at AntlerA Therapeutics and ModMab Therapeutics, two different companies that they joined in 2019. Somasekar is responsible for leading and overseeing the strategic direction of both organizations.

Prior to their current roles, Seshagiri served as the President of Science and Education at SGRF (SciGenom Research Foundation) starting in April 2019. In this position, they played a key role in advancing scientific research and education initiatives.

Seshagiri also has a long history of employment at Genentech, where they held several positions of increasing responsibility. Starting in April 1998, they served as an Associate Director and Staff Scientist until April 2019. During this time, they contributed to various scientific projects and played an important role in the organization. Additionally, they held the positions of Associate Director & Principal Scientist from April 1998 to March 2019.

Overall, Seshagiri's work experience showcases their expertise in biotechnology, leadership skills, and commitment to advancing scientific research and education.

Somasekar Seshagiri completed their education in a chronological order as follows:

- From 1993 to 1998, they pursued their Doctor of Philosophy (Ph.D.) degree in Genetics at the University of Georgia - Franklin College of Arts and Sciences.

- Between 1999 and 2002, they attended Golden Gate University where they obtained a Master of Science (MS) degree in Software Engineering.

- In the years 1989 to 1992, Somasekar Seshagiri studied at Tamil Nadu Agricultural University, completing a Master of Science (MS) degree in Biotechnology.

- Lastly, from 1995 to 1999, they pursued a Bachelor of Science (BS) degree in Agriculture at Tamil Nadu Agricultural University.